Lilly, A Joshua <br/><br/>
The case for extracellular Nm23-H1 as a driver of acute myeloid leukaemia (AML) progression.  [electronic resource] 

 -  Naunyn-Schmiedeberg's archives of pharmacology  Feb 2015 
 - 225-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1432-1912 
<br/><br/><label>Standard No.: </label>10.1007/s00210-014-1027-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Disease Progression<br/>Humans<br/>Leukemia, Myeloid, Acute--metabolism<br/>Mucin-1--metabolism<br/>NM23 Nucleoside Diphosphate Kinases--metabolism<br/>Receptors, Cell Surface--metabolism